Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Healthtrust
Teva
Citi
Express Scripts
Johnson and Johnson
McKinsey
QuintilesIMS
Queensland Health
Argus Health

Generated: June 23, 2018

DrugPatentWatch Database Preview

PHERAZINE DM Drug Profile

see a sample report or, see our see our flat-rate plans

« Back to Dashboard

When do Pherazine Dm patents expire, and when can generic versions of Pherazine Dm launch?

Pherazine Dm is a drug marketed by Halsey and is included in one NDA.

The generic ingredient in PHERAZINE DM is dextromethorphan hydrobromide; promethazine hydrochloride. There are twenty-three drug master file entries for this compound. Fourteen suppliers are listed for this compound. Additional details are available on the dextromethorphan hydrobromide; promethazine hydrochloride profile page.
Summary for PHERAZINE DM
US Patents:0
Applicants:1
NDAs:1
Formulation / Manufacturing:see details
DailyMed Link:PHERAZINE DM at DailyMed
Drug patent expirations by year for PHERAZINE DM

US Patents and Regulatory Information for PHERAZINE DM

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Halsey PHERAZINE DM dextromethorphan hydrobromide; promethazine hydrochloride SYRUP;ORAL 088913-001 Mar 2, 1987 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

see a sample report or, see our see our flat-rate plans

see a sample report or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Citi
Argus Health
Queensland Health
Chinese Patent Office
McKinsey
Cantor Fitzgerald
Fish and Richardson
US Department of Justice
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.